Currently, two vaccines - Covishield and covaxin - are being used in the ongoing vaccination campaign against Corona in India. A third vaccine may be added soon. This Russian vaccine is expected to be Sputnik V. Dr Reddy's Laboratory, a Hyderabad-based company in India, is conducting its trials and is expected to approach the drug regulator in March for emergency approval. This vaccine will be available in India for $ 10 (about Rs 730).
Of the 10 vaccines approved worldwide, Sputnik V as well as the vaccines of American companies Pfizer and Mordana have proved to be more than 90% effective. For this reason, the fight against Corona can be expected to be strengthened with the availability of the Russian vaccine in India. The Russian vaccine has been created by the Gamalaya Institute of Russia and funded by the Russian Direct Investment Fund (RDIF). RDIF is also doing the deal on this vaccine from around the world.
RDIF CEO Kirill Dmitriev said that the price of the Moderna and Pfizer vaccines, which currently prove more than 90% efficacy, is three times the price of Sputnik V. With this, the Russian vaccine is being tried to reach more and more countries all over the world. The good thing is that it can be stored at a temperature of 2 to 8 ° C which is readily available in the current supply chain. The Russian vaccine is composed of two adenovirus vectors. The company is currently in talks with British firm AstraZeneca on combined trials with its vaccine - CoveShield. The company claims that the effectiveness of the AstraZeneca vaccine will increase further.
India will have the most effective and affordable vaccine
If the Russian vaccine is successful in all trials and is approved in India, it will be the most effective vaccine in trials. The efficacy of the Covishield vaccine being used in India has been 70%, while the phase-3 trials of Covaxin have not been completed yet. Because of this, the situation regarding its effectiveness is not clear.
The government is getting one dose of Covshield for 200 rupees and one dose of Covaxin for 295 rupees. At the same time, CoviShield's dose in the market will be Rs 1,000. Covaxin has not yet disclosed the market price. In such a situation, Sputnik V priced at Rs 730 can be the cheapest and effective vaccine in the market.
Which countries have received approval so far
Dimitrev said Sputnik V has so far received approval in Russia, Belarus, Serbia, Argentina, Bolivia, Algeria, Palestine, Venezuela, Paraguay, UAE, Turkmenistan. Hungary has become the first country in the European Union to approve it. Approval can be obtained soon from the Drug Regulator of the European Union.
Amit Shah on UP mission: In Lucknow, Yogi Ji again, we will make UP the number one state
On reaching Lucknow, Home Minister Amit Shah was given a grand welcome at the airport by Chief Mi
India has won two worlds since 2007. One ODI and one T20 World Cup. Yuvraj Singh was made the Pla
Remdesivir injections were sold for 45 thousand, three arrested including women
Gurugram The game of black marketing of Remdesivir injection is going on indiscriminately in the
In the case of the murder of Hindu leader Sudhir Suri in Amritsar, Punjab on Friday, now Khalista
Good news has come for the world troubled by the food crisis, by the war between Russia and Ukrai
The petrol and diesel crisis has started in many parts of the country including Uttar Pradesh, Ra
Most of the states of North India are in the grip of severe heat and heatwave. The first week of
Sri Lankan Foreign Minister Ali Sabri said on Monday that his government has not allowed the Chin
Prime Minister Narendra Modi today addressed a webinar on the topic "Energy for Sustainable Growt
The Indian government objected to Twitter using the "manipulated media" tag for tweets on the too
